Market Overview:
Endobronchial ultrasound is a minimally invasive medical procedure used to examine the lungs and mediastinum. EBUS biopsy combines bronchoscopy with ultrasound to guide transbronchial needle aspiration for lung and mediastinal lesions. It has advantages of real time images and minimally invasive procedure that avoids surgery.
Market key trends:
One of the key trends in the endobronchial ultrasound biopsy market is the growing adoption of EBUS-TBNA (transbronchial needle aspiration) for diagnosis of lung cancer. According to American Cancer Society, lung cancer is the second most common type of cancer. Early diagnosis is important for improving outcomes. EBUS-TBNA has emerged as gold standard for diagnosis of lung cancer and mediastinal lymph nodes staging. It has high diagnostic yield, shorter procedure time and reduced risk of complications compared to surgery. The procedure provides real time images for precise needle aspiration of suspicious lesions under ultrasound guidance via bronchoscope.
Segment Analysis
The global endobronchial ultrasound biopsy market is segmented based on product type, application, end-user, and geography. Based on product type, the market is classified into needles, catheters, bronchoscopes, and ultrasound probes. The needles segment currently dominates the market owing to its high usage and demand for minimally invasive diagnostic and therapeutic procedures.
Key Takeaways
The global Endobronchial Ultrasound Biopsy Market Demand is expected to witness high, exhibiting CAGR of 9.0% over the forecast period, due to increasing prevalence of lung cancers and respiratory disorders.
Regional analysis
North America currently dominates the market due to advanced medical infrastructure and favorable reimbursement policies. Asia Pacific is expected to grow at the fastest rate during the forecast period due to rising awareness, improving healthcare expenditure, and increasing incidence of lung cancer in the region.
Key players
Key players operating in the endobronchial ultrasound biopsy market are Fujifilm Holdings Corporation, Olympus Corporation, Hitachi Medical Corporation, Pentax Medical (Hoya Corporation), Boston Scientific Corporation, Cook Medical, Carl Zeiss Meditec AG, Medtronic plc, BARD Diagnostic Systems, Inc., and ACON Laboratories, Inc. These players are focusing on new product launches and strategic collaborations to gain maximum share in the market.
Get more insights on this topic:
https://www.newswirestats.com/endobronchial-ultrasound-biopsy-market-demandanalysis/
Comments
0 comment